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Objectives: to evaluate the prevalence of familiar abdominal aortic aneurysm (AAA) and the role of type III collagen
deficiency.
Methods: fifty-six consecutive patients coming for aneurysm repair were asked if one or more first-degree relatives had
an AAA. During operation, a skin biopsy was taken from the patients for protein analysis to measure the type III collagen
production in cultured fibroblasts.
Results: a positive family history was found in 28.6% of the AAA patients. Six (10.7%) of the AAA patients had a type
III collagen deficiency (mean 4.3% (S.D.–0.5)). In this group three men, mean age 65.3 years (S.D.–5.0), had a positive
family history and a type III collagen deficiency. Segregation analysis with an intragenic marker in the type III collagen
gene in a single family was in favour of linkage with the gene for type III procollagen (COL3A1) locus.
Conclusions: the high prevalence of familial AAA suggests a genetic aetiology. A small group of patients have a type
III collagen deficiency. Linkage with the COL3A1 gene could not be proven or excluded in the families studied.
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Introduction collagen and elastin, resulting in abnormalities in the
structure, synthesis, or secretion of these components.
Elastin deficiency, as found in Williams syndromeThe incidence of abdominal aortic aneurysm (AAA)
(deletion of the ELN gene) leads to supravalvularis still increasing. Ultrasound screening of 2416 Dutch
aortic stenosis and not to aneurysms.7 The fibrillarmen between 60–80 years showed a prevalence of 8.1%
collagen network provides most of the tensile strengthfor AAA [4 cm (Boll APM Presentation Nov. 97).
of the aortic wall. The network contains predominantlyMortality after elective surgery for abdominal aortic
types I and III collagen, with the tensile characteristicsaneurysms varied between 1.4 and 6.5% in Dutch
being attributed to type III. Deficiency of type IIIhospitals;1 nevertheless, the overall mortality including
collagen in the Ehlers–Danlos syndrome type IV isruptured AAA is still high.
characterised by sudden death from rupture of thePathology of aneurysmal dilatation has been the
aorta and spontaneous dissections. The familial clus-subject for many investigations. Environmental factors,
tering of AAA indicates a hereditary component. Aincluding ageing and smoking and haemodynamic
possible explanation of familial AAA can be a pheno-factors, including hypertension, are common risk fac-
typic overlap between familial arterial aneurysms andtors.2 Evaluation of the inflammatory response shows
Ehlers–Danlos syndrome type IV.8 Deak et al.9 alreadyan expression of prostaglandin E2 to be associated
demonstrated a reduced ratio of type III to type Iwith the pathogenesis of AAA.3
collagen in aortic aneurysms.Genetic factors are also associated with the de-
In the present study we performed protein analysisvelopment of AAA.4–6 A genetic predisposition may
of type III collagen in patients with an AAA. Wecause defects in the structural components of the aorta,
studied the prevalence of (a) a positive family history
for AAA and (b) a type III collagen deficiency in
* Please address all correspondence to: C. van Keulen, Academisch patients with AAA. Furthermore, we studied se-
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gregation of the gene for type III procollagen (COL3A1)Boelelaan 1117, P.O. Box 7057, 1007 MB Amsterdam, The Neth-
erlands. in one family with more members with an AAA.
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Patients and Methods cholesterol <6.2 mmol/l, triglycerides <2 mmol/l,
HDL cholesterol >0.9 mmol/l and/or LDL cholesterol
Patients <5.0 mmol/l. The Hospital Ethical Committee ap-
proved all procedures.
Between August 1994 and January 1996 we studied
56 consecutive, unrelated patients referred for an ab-
dominal aortic aneurysm to the department of surgery,
Protein analysisdivision of vascular surgery, of our hospital. The diag-
nosis was confirmed by ultrasound and/or by com-
A skin biopsy was taken during operation for fibroblastputed tomography. An abdominal aortic aneurysm
culture. Control cell lines were derived from skinwas defined as an aortic diameter greater than 3 cm
biopsies from healthy control subjects (mean age 43.5in the infrarenal portion of the aorta, or a diameter of
years (s.d.–8.2)).50% greater than the normal suprarenal aorta.10 An
Fibroblasts were cultured to confluence in 25 cm2aortic diameter greater than 4 cm was an indication
flasks in HAM F10 (Life Technologies) with 10% fetalfor operation.
calf serum. Metabolic labelling was performed for 20At the time of hospital visit we recorded the medical
hours in 2 ml BME proline free media (Life Tech-and family history. We searched for the presence of
nologies) containing 5% dialysed fetal calf serum,aneurysms in any of their first-degree relatives. A
37 lg/ml L-ascorbic acid, 2 lCi/ml L-[U-14C]-Prolinepositive family history was defined as one or more
(Amersham). After ethanol precipitation of aliquots offirst-degree family members with an AAA mentioned
333 ll of media, the pellets were dissolved in 150 llby the patient and diagnosed by a physician. In ad-
0.5 M acetic acid. One aliquot of each sample wasdition, we recorded the presence of classical risk factors
treated with pepsin for the analysis of collagen; un-like smoking habits (duration and amounts per day),
treated aliquots were used for procollagen. The cellsthe presence of hypertension (WHO criteria), diabetes
were trypsinised, centrifuged, washed and frozen asmellitus and hypercholesterolaemia (diagnosed by a
dry pellets. The pellets were homogenised in 150 llphysician). Furthermore, we scored atherosclerotic
0.5 M acetic acid. After centrifugation the supernatantsmanifestations such as peripheral, coronary and
were used for electrophoresis. After liquid scintillationcerebral arterial occlusive disease. Peripheral arterial
counting 20 000 c.p.m. aliquots of the samples (betweenocclusive disease was defined by presence of in-
5 and 10 ll) were lyophilised, dissolved in 20 ll sampletermittent claudication confirmed by ankle/arm index
loading buffer (Promega) and subjected to SDS PAGE<0.9 and/or decrease of >0.15 of the index after tread-
in a Protean II electrophoresis system (BioRad). Aftermill exercise testing, or ischaemic rest pain, gan-
90 minutes at 200 V (10E C) the samples were reducedgrenous ulcers, or amputation for ischaemia. Coronary
in the gel by addition of 30 U of DTT solution (7.7 mg/artery occlusive disease was defined as the presence
ml in 40% saccharose) in each slot (reduction ofof myocardial infarction (WHO clinical definition plus
samples prior to electrophoresis leads to overlap ofnew Q waves on electrocardiography and/or diag-
type I and III collagens). After another 90 minutes atnostic enzyme changes). Cerebral arterial occlusive
400 V the gels were dried and analysed with a Phos-disease was defined by the presence of symptomatic
phor Imager (Molecular Dynamics).12 A type III col-cerebral vascular disease (ischaemic stroke or transient
lagen deficiency was defined as a type III collagenischaemic attack, WHO clinical definitions) and, in case
percentage less than 5% of total collagen productionof stroke, was confirmed by computed tomography.
after protein analysis of cultured fibroblasts.The prevalence of familial AAA obtained by in-
terview is probably an underestimate. Our next study
compares familial AAA obtained by interview with
ultrasound examination of family members. To exclude
Segregation analysispatients with an Ehlers–Danlos type IV syndrome, the
emphasis in physical examination was on skin changes
A DNA tandem repeat marker in intron 25 of thelike ecchymoses, scarring, heavy pigmentation and
COL3AI gene was studied using the PCR primers andeasy bruisability. After an overnight fast, venous blood
methods described by Mays.13 We used CY5 labelledsamples were taken for measurement of serum lipids
dCTP in the PCR reaction to label the PCR products.(total and high density lipoprotein [HDL] cholesterol
The exact length of the alleles was assessed on anand triglycerides [enzymatically], low density lipo-
ALFExpress automated DNA sequencer (Pharmacia,protein [LDL] was calculated by Friedewald’s for-
mula).11 Reference values in our hospital are for total Uppsala, Sweden).
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Fig. 1. Segregation analysis of the gene for the type III procollagen in the family with aortic aneurysms. Age-affected relatives II-9, III-1
and III-3 are respectively 68, 58, 50 years. Black squares indicate those in whom aortic aneurysm was diagnosed; I-III=different generations;
% col 3=type III collagen percentage (type III collagen deficiency was defined as a type III collagen percentage less than 5% of total
collagen production after protein analysis of cultured fibroblasts); marker alleles=length in bases of the variable DNA repeat.
Statistics (mean 4.3 (s.d.–0.5)) after protein analysis were all
men. The mean ages of these patients is 67.8 years
Data were analysed using the statistical package SPSS (s.d.–9.0). In this group three patients, mean age 65.3
years (s.d.–5.0) had one or more first-degree relativesfor Windows 6.1. Descriptive data are given as mean
(s.d.). Continuous variables were tested by Student’s with an AAA. Three patients, mean age 70.3 years
(s.d.–12.6) had a type III collagen deficiency withoutt-test (for means). Percentages were compared by Chi-
squared test. All testing was two-tailed with 0.05 as a positive family history. Table 2 represents the type
III collagen deficiency in patients with or withoutthe level of significance.
familial AAA. These data did not differ significantly.
Protein analysis of 40 healthy control subjects showed
no type III collagen deficiency (9.7 (s.d.–3.7)). We
Results studied procollagen in the patients with a decreased
type III collagen. There was no qualitative differenceThe patient group consisted of 52 men and four of procollagen in this group. In all patients intracellularwomen. Three women and 13 men (28.6%), with a collagen was studied and no indications were foundmean age of 66.4 years (s.d.–8.3) knew of at least one of accumulation.first-degree relative with an AAA. From the patients In one large family (Fig. 1) we studied segregationwith a positive family history, four fathers, four broth- of the COL3A1 gene and the presence of AAA, usingers of an affected father, two mothers, 10 brothers and a DNA repeat marker in intron 25. One allele, 240three sisters also had an AAA. A 50-year-old patient bases in length, was found in all affected individualshad five other relatives with an AAA (four uncles, one and in one obligate carrier. This allele was not foundbrother, Fig. 1). in any of the unaffected relatives. This results in LODTable 1 shows the important risk factors of the score of 1.5 with no recombination.patients. These risk factors were not significantly dif-
ferent between the patients with or without familial
AAA. In this small group there are significantly more
women with familial AAA (p=0.03). The laboratory Discussion
levels of HDL-cholesterol were significantly higher in
the group with familial AAA compared to the group The family history in all families was in agreement
with an autosomal dominant inheritance with reducedwithout familial AAA (p=0.05).
The six patients with a decrease of type III collagen penetrance. Tilson and Seashore et al.14 state that, if
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Table 1. Clinical and laboratory characteristics of patients with and without familial
abdominal aortic aneurysm (AAA).
Patients with familial Patients without familial
AAA* AAA
n=16 n=40
Male/Female, n 13:3 39:1
Age, years 66.4 (8.3) 69.3 (6.5)
Hypertension, n (%) 9 (56.2) 26 (65.0)
Hypercholesterolaemia, n (%) 6 (37.5) 9 (22.5)
Coronary arterial occlusive disease, n 4 (25.0) 20 (50.0)
(%)†
Peripheral arterial occlusive disease, n 5 (31.2) 8 (20.0)
(%)†
Cerebral arterial occlusive disease, n 2 (12.5) 3 (7.5)
(%)†
Diabetes mellitus, n (%) 0 2 (5.0)
Current smoking, n (%) 8 (50.0) 14 (35.0)
Past smokers, n (%) 14 (87.5) 38 (95.0)
Pack years‡ 27.4 (20.9) 30.8 (20.9)
Body mass index (kg/m2)§ 25.0 (4.0) 25.1 (3.0)
Total cholesterol (mmol/l) 6.1 (1.5) 5.8 (1.2)
Triglyceride (mmol/l) 2.1 (1.1) 1.8 (1.2)
HDL-cholesterol (mmol/l) 0.8 (0.2) 1.1 (0.4)
LDL-cholesterol (mmol/l)¶ 4.4 (1.2) 4.1 (1.1)
Diameter abdominal aneurysm (cm)** 6.8 (2.8) 5.6 (1.1)
Data are given as number (n) with percentage in parentheses or as mean (s.d.)
* Familial AAA was defined as one or more first-degree family members with an AAA
mentioned by the patient and diagnosed by a physician.
† Coronary, peripheral, cerebral arterial occlusive disease as defined in patients and methods.
‡ Pack years were calculated by multiplying the number of cigarette packages smoked per day
by the number of years the patient smoked. § Body mass index was calculated as weight/
height2. ¶ LDL-cholesterol was calculated by Friedewald’s formula. **Diameter abdominal
aneurysm as diagnosed by ultrasound or computed tomography.
Table 2. Prevalence of type III collagen deficiency in patients with and without familial
abdominal aortic aneurysm (AAA).
Familial AAA* Non-familial AAA
n=16 (28.6) n=40 (71.4)
Type III collagen deficiency, n (%)† 3 (18.8) 3 (7.5)
(mean 4.3 (s.d.–0.5))
Normal type III collagen, n (%) 13 (81.2) 37 (92.5)
(mean 11.0 (s.d.–2.9))
Data are given as number (n) with percentage in parentheses or as mean (s.d.).
* Familial AAA was defined as one or more first-degree family members with an AAA
mentioned by the patient and diagnosed by a physician.
† Type III collagen deficiency was defined as a type III collagen percentage less than 5% of
total collagen production after protein analysis of cultured fibroblasts.
only one gene is responsible for familial AAA, it is of AAA patients after ultrasound screening of first-
degree relatives. They concluded that screening oflikely to be autosomal. Through questionnaire and
phone inquiry Verloes et al.15 also examined the familial siblings older than age 55 years is recommended be-
cause of the high prevalence of undiagnosed AAA byclustering of AAA. Familial data on 324 probands
with AAA allowed the establishment of 313 multi- ultrasound. Bengtsson et al.17 found a similar per-
centage (29%) of AAA in brothers of patients withgenerational pedigrees. They explain the occurrence
of AAA (>30 mm) as a single gene effect showing aneurysms. Recently, Lederle et al.18 reported a family
history of AAA to be positively associated with AAA.dominant inheritance with low age-dependent pene-
trance. In this study 5.1% (odds ratio 1.59 [95% confidence
interval 1.56 to 2.43]) of 73 451 US veterans betweenIn this study the prevalence of a family history for
AAA was 28.6% in patients with this disorder. Webster 50 to 79 years of age confirmed a positive family
history for AAA. Unfortunately, the authors did notet al.16 found an incidence of 25% of AAA in siblings
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mention the definition of a positive family history. production should have resulted in a higher specific
activity and lower sample volume. This was not theKuivaniemi et al.19 and other authors mention that
AAA can be familial as a result of genetic defects. case for the samples with a low type III/I collagen ratio.
Therefore a decreased type III collagen production isIn 1975 Pope et al.20 identified a type III collagen
abnormality as the basic defect of type IV Ehlers– the most likely explanation for the decreased ratio in
these samples. The type III/I collagen ratio showedDanlos syndrome (EDS). Type III collagen is an im-
portant fibrillar protein in walls of blood vessels and no decrease with age, so it is unlikely that the lower
mean age of the control group has affected the results.large bowel. Lethal complications of this syndrome
can be a tear in large and medium-sized arteries or in In our study only six of the 56 (10.7%) aneurysm
patients had a type III collagen deficiency. Three (5.4%)other hollow organs. Type IV EDS is an autosomal
dominant heritable disease, but frequently there may of these patients had a positive family history (50%).
Segregation analysis with an intragenic marker inbe single affected individuals in families. The bio-
chemical abnormality differs from case to case. Every the type III collagen gene was performed in a single
family, because no other families were found with atype IV EDS patient has his own type III collagen
disorder; within a family the same type III collagen sufficient number of surviving affected members. The
results in this family were in agreement with linkagedisorders can exist.21–24 The different type III collagen
defects lead to variable clinical signs in the affected at the COL3A1 locus. However, due to the limited
number of affected individuals that could be studied,individuals. In 1987 Menashi et al.25 compared the
collagen content of the media of infrarenal aorta in the LOD score was only 1.5 at zero recombination,
assuming dominant inheritance, with reduced pene-normal aorta dilated and non-dilated atherosclerotic
aorta. After SDS–polyacrylamide gel electrophoresis trance (individual II-1 is non-penetrant). Under a
model of recessive inheritance, linkage at this locusof specific cyanogen-bromide peptides, the ratio of I
to III collagen did not differ in any of the three groups is unlikely, because at least two recombinations are
present (individuals II-1 and III-3). The frequency ofof aortas, although three patients with a positive family
history for AAA had lower concentration of type III the 240 bp COL3A1 allele is not known in the Dutch
population. According to the CEPH database (http://collagen in the aorta media. Rizzo et al.26 noted in his
study that there was no difference in type III collagen www.cephb.fr.) the frequency of the 240 allele is 5.4%
in West European Caucasians. Linkage to the COL3A1content in full-thickness aorta in patients with or with-
out a positive family history. He was convinced that locus does not necessarily mean involvement of type
III collagen. The COL5A2 gene, encoding the type Velastin degradation plays a role in the development
of atherosclerotic aneurysms. After DNA analysis of collagen alpha 2 chain, is closely linked to the COL3A1
gene. Type V collagen could play an important rolerelatives with aortic aneurysms a single-base mutation
that converted the codon for glycine 619 of the alpha in AAA, because it determines fibril diameter and may
affect the tensile strength of the intracellular matrix.I (III) chain of type III procollagen to a codon for
arginine, resulting in a collagen that is thermally un- Linkage analysis with a larger number of pedigrees is
stable, was identified.27 In 1993 Powell et al.28 could necessary to detect possible genes that are involved
not confirm their previous claim that a mutation at in AAA.
amino acid 619 of glycine to arginine was associated In conclusion, we confirmed that more than a quarter
with aneurysms in 153 patients with AAA. They sug- of AAA patients have one or more first-degree relatives
gest that the ageing aorta and changing mechanical with an AAA. No obvious aetiology differences were
stability of the artery may be influenced by variation found in the group with a positive and negative family
in the type III collagen gene. A role of the rare Ava II history for AAA. In women, more positive family
allele of the type III collagen, determined by Southern histories were found. Only a minor percentage of the
blotting, is disputable. In the AAA group the presence AAA patients with a positive family history for AAA
of the Ava II rare allele was associated with a significant had a type III collagen deficiency. Linkage with the
increase in aneurysm diameter, but the frequency of COL3A1 gene could not be proven or excluded.
this allele was found in the AAA group as often as in
the general population.
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